Northland Starts ARS Pharmaceuticals Inc (SPRY) at Outperform, 'Disrupting the Injectable Epinephrine Market'
Tweet Send to a Friend
(Updated - April 9, 2026 6:55 AM EDT)
Northland analyst Carl Byrnes Jr. initiates coverage on ARS Pharmaceuticals Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Northland analyst Carl Byrnes Jr. initiates coverage on ARS Pharmaceuticals Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
